Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.11 -0.04 (-3.48%)
At close: Nov 13, 2026 · 4:00 PM EST

Veraxa Biotech AG - Post de-SPAC (VRXA) Total Liabilities (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC's Total Liabilities came in at $120.85 million for the quarter ended Dec 31, 2025, up 97.1% from $61.31 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Total Liabilities (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC's Total Liabilities was $116.5 million, up 90.8% from the prior year.

  • Going back by year, Total Liabilities was $61.05 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 115.90 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 152.26 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 38.37 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 115.70 Bn
10 Veraxa Biotech AG - Post de-SPAC 16.07 Mn 12.50 Mn - 226.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 226.60 Mn
Dec 31, 2024 39.64 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=VRXA&period=max&api_key=YOUR_API_KEY